Biovie Inc.
Clinical trials sponsored by Biovie Inc., explained in plain language.
-
Could this pill clear long COVID brain fog? new trial begins
Symptom relief OngoingThis study tests a drug called bezisterim (NE3107) in 203 adults with long COVID who struggle with brain fog and fatigue. Participants take either the drug or a placebo twice daily for 84 days, and researchers measure changes in thinking, memory, and energy levels. The goal is to…
Phase: PHASE2 • Sponsor: BioVie Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could this pill delay Parkinson's progression? new trial begins
Symptom relief OngoingThis study tests a drug called bezisterim (NE3107) in 60 people with early Parkinson's disease who have not yet started standard treatment. The goal is to see if it can improve movement symptoms like stiffness and slowness. Participants take the drug or a placebo twice daily for …
Phase: PHASE2 • Sponsor: BioVie Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC